Influence of alpha‐adrenoceptor antagonists therapy on stool form in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia-Reference-Cited by-同舟云学术

Influence of alpha‐adrenoceptor antagonists therapy on stool form in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

Published:2019-08-29 Issue:1 Volume:12 Page:86-91
ISSN:1757-5664
Container-title:LUTS: Lower Urinary Tract Symptoms
language:en
Short-container-title:Lower Urinary Tract Symptoms

Author:

Matsumoto Seiji¹²^ORCID,Kasamo Sachiko²,Hashizume Kazumi³

Affiliation:

1. Center for Advanced Research and EducationAsahikawa Medical University Asahikawa Japan

2. Clinical Research Support CenterAsahikawa Medical University Hospital Asahikawa Japan

3. Department of UrologyKoga Hospital Abashiri Japan

Publisher

Wiley

Subject

Urology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/luts.12289

Reference22 articles.

1. American Urological Association Guideline: Management of Benign Prostatic Hyperplasia (BPH) Revised 2010. Published 2010; Reviewed and Validity Confirmed 2014. Available from URL:https://www.auanet.org/benign-prostatic-hyperplasia-(2010-reviewed-and-validity-confirmed-2014)

2. EAU Guidelines on the Management of Non‐Neurogenic Male Lower Urinary Tract Symptoms (LUTS) incl. Benign Prostatic Obstruction (BPO). Available from URL:https://uroweb.org/wp-content/uploads/EAU-Guidelines-Non-Neurogenic-Male-LUTS-Guidelines-2015-v2.pdf

3. Outline of JUA clinical guidelines for benign prostatic hyperplasia

4. New alpha blockers to treat male lower urinary tract symptoms

5. Silodosin, a new ?1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative efficacy and safety of alpha-blockers as monotherapy for benign prostatic hyperplasia: a systematic review and network meta-analysis;Scientific Reports;2024-05-15

2. Comparison of disease‐specific quality of life in prostate cancer patients treated with low‐dose‐rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil;International Journal of Urology;2021-08-10

3. Innovative Thermobalancing therapy and Dr Allen’s Device for the first time employ body energy to treat chronic prostatic diseases effectively;International Journal of Quality Innovation;2020-06-09